Condition
Muscular Atrophy, Spinal clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Muscular Atrophy, Spinal clinical trials that are recruiting, at sites in 13 countries (most in United States (4), Italy (2), United Kingdom (2)). By phase: Phase 3 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 13Countries
Newest Muscular Atrophy, Spinal clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Salanersen after early gene therapy in babies with SMA | Phase 3 | Flower Mound, Texas | Recruiting | Mar 3, 2026 |
| Salanersen given before symptoms to help movement in babies with genetic SMA | Phase 3 | Chicago, Illinois and 13 other locations | Recruiting | Oct 28, 2025 |
| Understanding how nusinersen is processed in the body using a new delivery system for spinal muscular atrophy | Phase 1 | Phoenix, Arizona and 20 other locations | Recruiting | Aug 15, 2024 |
| Evaluating pregnancy outcomes in women with spinal muscular atrophy exposed to Spinraza | — | Palo Alto, California and 13 other locations | Recruiting | Mar 29, 2023 |
| Observing the natural history of spinal muscular atrophy | — | Genova and 4 other locations | Recruiting | Mar 6, 2023 |
All recruiting trials (5)
-
Salanersen after early gene therapy in babies with SMA
This study tests whether adding salanersen (BIIB115) after early gene therapy with Onasemnogene abeparvovec helps babies with SMA.
-
Salanersen given before symptoms to help movement in babies with genetic SMA
This study will try salanersen in newborns with genetically confirmed SMA who have 2 or 3 copies of SMN2 to see if starting treatment before symptoms prevents or lessens movement problems.
-
Understanding how nusinersen is processed in the body using a new delivery system for spinal muscular atrophy
This study is testing a new way to deliver the medication nusinersen for spinal muscular atrophy to see how it works in the body compared to the usual method.
-
Evaluating pregnancy outcomes in women with spinal muscular atrophy exposed to Spinraza
This study is trying to see how pregnancy goes for women with spinal muscular atrophy who have used Spinraza, compared to women without the condition who haven't used the drug.
-
Observing the natural history of spinal muscular atrophy
This study is trying to understand how spinal muscular atrophy affects patients over time by looking at their experiences and health data from both treated and untreated individuals.
Quick answers
How many Muscular Atrophy, Spinal clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 13 countries. The most sites are in United States (4 trials), Italy (2 trials), United Kingdom (2 trials), Australia (1 trial), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.